Metlife Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
12.0%projected annual EPS growth
Analyst Coverage
16analysts covering
FY EPS (est.)
$9.80next fiscal year
Monitoring Framework
Key Performance Indicators
Adjusted Earnings Per Share (EPS) Quarterly2.4Target: Double-digit annual growth under New Frontier strategy
Adjusted Return on Equity (ROE) Quarterly17.0Target: 15% to 17%
Direct Expense Ratio Quarterly1,190.0%Target: Below 12.3% target
Variable Investment Income (VII) Quarterly518MTarget: 1600000000 annually
Watch Items
- Variable Investment Income (VII) VolatilityTrigger: Quarterly VII falling below $300 millionAction: Re-evaluate private equity and real estate market exposures and adjust portfolio allocation.
- Group Benefits Underwriting MarginsTrigger: Direct expense ratio exceeding 12.5% or elevated claims experienceAction: Review pricing models, voluntary benefit expansion, and cost-control measures.
- Retirement and Income Solutions (RIS) SpreadsTrigger: Interest rate cap roll-offs causing base spread compression of more than $0.20 per shareAction: Assess hedging strategies and capital flexibility across U.S. and Japan platforms.
Research as of 2 Sep 2026